Zdrowie i gospodarka · 04/05/1998
FDA Announces Draft Guidance on Testing for Skin Sensitization to Chemicals in Latex Products
The FDA is releasing a draft guidance document to help medical device manufacturers make alternative claims for products containing natural rubber latex, replacing the 'hypoallergenic' label that will no longer be acceptable after September 30, 1998.